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Abstract 
Acute myocardial infarction and type two diabetes are within the top seven causes of death in the 
United States and their impact on society is costly. Although there are many studies conducted 
about these diseases, some of the research is aged and requires more recent datasets. The 
objective of this research is to revel trends in these diseases, as well as in their comorbidity, 
relating to age, gender, and race. To conduct this research, data has been collected from the CDC 
Wonder dataset using their comorbidity database. This comorbidity data uses USA death 
certificates from 1999-2017 to retrieve the medical information from each state. The data pulled 
was then analyzed using two SPSS tests, ANOVA and independent T test, to discern significance 
and visualize trends.  Data from the two ANOVA tests and one independent T test involving type 
two diabetes and acute myocardial infarction shows statistically significant differences regarding 
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mortality involving those age 65+ as well as persons identifying as White or Black/African 
American. Using the same tests to analyze type two diabetes reveals significant differences 
regarding mortality involving those age 65+ or identifying as Asian/Pacific Islander. Finally, 
results from the two ANOVA tests and the independent T test analyzing the co-mortality of acute 
myocardial infarction and type two diabetes showed a significant difference in mortality for 
those age 65+ or identifying as Asian/Pacific Islander.  





Introduction/Literature Review  
Acute myocardial infarction and type two diabetes are within the top seven causes of death in 
the United States and their impact on society is costly. The objective of this research is to 
investigate the connection between age, gender, and race and comorbidity of type 2 diabetes and 
acute myocardial infarction. In this introduction, we first identify the existing literature of type 2 
diabetes and acute myocardial infarction separately, then discuss comortality of these diseases, 
ending with identifying gaps in the literature and how our study begins to address these gaps. 
Type 2 Diabetes 
Type 2 diabetes is a disease defined by the interaction between the body and glucose. When 
nutrients are consumed and absorbed, glucose enters the bloodstream and begins to move into 
the tissues and organs of the body, supplying them with energy to carry out basic metabolic 
processes. The absorption of glucose from the blood to tissues is where the mechanism of type 2 
diabetes can be found. Glucose is normally absorbed into cells through glucose transporters and 
one of the insulin dependent ones is the GLUT4 transporter. This transporter’s presence on the 
cell surface is determined by insulin signaling. In type 2 diabetes, the insulin signal is not 
effectively transported and glucose remains in the blood, leading to hyperglycemia and the signs 
and symptoms of the disease.1 In a research paper conducted at Appalachia State University, 
using data collected from the Center for Disease Control, there is existing data showing how both 
incidence and prevalence of type 2 diabetes increased since 1980.2 One of the points of this 
research will be to confirm this trend and show patterns with age and gender to the mortality of 
type 2 diabetes.  
Acute Myocardial Infarction 
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The term myocardial infarction has been defined differently over the past twenty-one years 
and with new labs, imaging techniques, and molecular mechanisms being discovered, the 
definition of the term will continue to change. One of the more recent definitions for myocardial 
infarction was provided by Dr. Louis Buja from the University of Texas. His definition described 
five different techniques/subtypes of myocardial infarction including primary atherothrombotic 
coronary event, sudden cardiac death, and coronary stent thrombosis to name a few.3 
Demographic trends involving mortality from acute myocardial infarction involving race, age, 
and gender were identified over years of research. Some examples include increased risk for 
acute myocardial infarction for Native Hawaiians as compared to Caucasians.4 Age as a variable 
has also been the focus of many studies, some with conflicting data. One study using the 
American Heart Association's Coronary Artery Disease national registry found that patients are 
being diagnosed at younger ages in more recent years.5 Another study found the opposite, with 
older populations showing increased prevalence of diagonosis.6 Gender and its connection with 
acute myocardial infarction was studied, with some researchers attributing higher mortality rates 
with males rather than females.7 Using the CDC Wonder dataset, all of the documented subtypes 
of myocardial infarction can be searched for and set as a variable under the code UCD-IDC I21. 
Using this tool, this project aims to understand trends within myocardial infarction as well as its 
connection to type 2 diabetes.  
Comorbidity of Type 2 Diabetes and Acute Myocardial Infarction  
Within the top ten causes of death in the US population, heart disease is the leading cause 
of death and generalized diabetes is ranked seventh.8 A novel approach to studying these two 
diseases is analyzing the possibility of  shared mortality between them. These two diseases are 
documented as being connected through comorbidity documentation in hospitals around the 
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world.9,10 This project plans to understand connections between type 2 diabetes and myocardial 
infarction in the scope of “mortality” as opposed to “morbidity”. The morbidity of a disease is 
defined as the condition of having a certain disease whereas mortality is death resulting from the 
disease. When speaking of comorbidity, the analysis would include subjects who had active 
diagnoses of both diseases in question. For the definition of co-mortality, based on the CDC 
Wonder Dataset, the death certificate of the individual must include both of the diagnoses on the 
document. Connections between type 2 diabetes and acute myocardial infarction have already 
been researched regarding gender, socioeconomic status, and many other demographics by 
universities and hospital systems around the globe. One trend is the increased risk of 
experiencing an acute myocardial infarction if the patient is already diagnosed with type 2 
diabetes.11 This paper will aim to show the connection and certain risk factors these two diseases 
have across the population of the United States.   
Gaps in the Literature 
One interesting point while discussing these two diseases is the comorbidity between them. A 
study from the American Diabetes Association found that the rate for event rate for co- 
morbidity of major coronary heart disease and type 2 diabetes was markedly increased in 
comparison to developing coronary heart disease in those without diabetes.12 Although this 
research does present a similar objective to this project, there are three key distinguishing factors 
this project aims to address. First, Dr. Juutilaninen et. al’s research was published in 2004, 
lending this topic to be readdressed with updated data. Secondly, this research paper will narrow 
the variable of coronary heart disease to myocardial infarction to provide a more focused topic 
with less internal variability. And finally, the population studied in Dr. Juutilaninen et. al’s 
research was 1,375 Finnish natives, whereas this study will analyze the population of recorded 
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deaths across the entire United States of America between the years of 1999 and 2017. With 
these added parameters and varied methods, we aim to produce data that will show an accurate 




1. How does age affect mortality from type 2 diabetes? 
2. How does gender affect mortality from type 2 diabetes? 
3. How does race affect mortality from type 2 diabetes? 
4. How does age affect mortality from acute myocardial infarction? 
5. How does gender affect mortality from acute myocardial infarction? 
6. How does race affect mortality from acute myocardial infarction? 
7. How does age affect comortality for type 2 diabetes and acute myocardial infarction? 
8. How does gender affect comortality for type 2 diabetes and acute myocardial infarction? 




This research was conducted using data collected from humans compiled from the CDC Wonder 
Database. The CDC Wonder Database collected this mortality information from US death 
certificates. The Multiple Causes of Death and Detailed Mortality databases collected the 
mortality data from each county in the US based on death certificates from residents. These 
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certificates included information regarding primary cause of death, additional causes of death, 
age, place of residence, race, gender, and year. Additional information was available for urban 
areas which included day of the week, location of death, and autopsy status. The data is collected 
and updated annually. The data itself is collected by the Vital Statistics Cooperative which 
includes the following agencies: the U.S. Department of Health and Human Services (US 
DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics 
(NCHS), Division of Vital Statistics (DVS), Mortality Statistics Branch. 
Data Collection 
I collected the data from the CDC Wonder Database. I used the Multiple Causes of Death and the 
Detailed Mortality databases. The two causes of death specified for this project are Type 2 
Diabetes (non-insulin dependent diabetes, UCD-IDC E11) and Acute Myocardial Infarction 
(UCD-IDC I21). The four parameters I used to create the datasets for each of these diseases were 
gender, age, race, and years 1999-2017, using data from all 50 states and the District of 
Columbia. All data available was included except for MI individuals less than 15 years old due 
to few states reporting this data. Parameters I did not include were specific location and day of 
the week. I did not include the location parameter in particular to ensure the largest, nationwide 
view that will standardize any fluctuation between those variables.  
 
Data Analysis 
Research questions 1,3,4,6,7, and 9 all aim to analyze the impact of age or race on mortality from 
type 2 diabetes or acute myocardial infarction. These contain comparison analyses. For example, 
the first research question focused on comparing different age groups for their mortality to type 2 
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diabetes. To compare these different groups, I used the ANOVA test to determine if there was a 
significant difference and then used a Post-hoc test to show which groups in particular were 
significant. This data was also used to analyze the impact between a certain age range and higher 
mortality to type 2 diabetes. Descriptive stats will be collected for each of the research questions. 
Research questions 2,5, and 8 required a different test because the gender variable only having 
two available categories. An independent t-test with descriptive analysis was conducted, 
allowing to compare means and test for a significant difference between the genders. This test 
was conducted for each of the diseases individually and then using the comortality data.  
Results  
RQ1: How does age affect mortality from type 2 diabetes? 
Three age groups were statistically significantly different when compared to each other age 
group’s mean mortality rate from type 2 diabetes. For each of the age groups of 65-74, 75-84, 
and 85+, their mean mortality rate from type 2 diabetes (18.40, 43.26, and 92.66, respectively) 
was statistically significantly higher (p<.05) than all the younger age groups and also statistically 
significantly lower (p<.05) than all the older age groups (Table 1). Each of the other, younger 
age groups were not statistically significantly different in comparison to each other when 




RQ2: How does gender affect mortality from type 2 diabetes? 
The means for the mortality rates from type 2 diabetes in males (M=6.2, SD=2.2) and females 
(M=6.1, SD=2.2) were not statistically significantly different.  
 
RQ3: How does race affect mortality from type 2 diabetes? 
The only statistically significant difference in mean mortality rate from type 2 diabetes was from 
persons identifying as Asian or Pacific Islander (Table 2). Asian or Pacific Islander mortality rate 
(2.50) was statistically significantly lower than the mortality rate for American Indian or Alaska 




RQ4: How does age affect mortality from acute myocardial infarction? 
Similar to type 2 diabetes, the oldest three age groups were statistically significantly different 
when compared to each other age group’s mean mortality rate from acute myocardial infarction. 
For each of the age groups of 65-74, 75-84, and 85+, their mean mortality rate from myocardial 
infarction (122.25, 294.40, and 763.66, respectively) was statistically significantly higher (p<.05) 
than all the younger age groups and also statistically significantly lower (p<.05) than all the older 
age groups (Table 3). Additionally, the mean morality rate for the 25-34 age group (1.08) was 




RQ5: How does gender affect mortality from acute myocardial infarction? 
The means for the mortality rates from acute myocardial infarction in males (M=52.6, SD=19.6) 
and females (M=40.8, SD=14.7) were not statistically significantly different (p>.05).  
 
RQ6: How does race affect mortality from acute myocardial infarction? 
Two racial categories were identified as being statistically significantly different when 
comparing the mean morality rates form acute myocardial infarction (Table 4). Black or African 
American persons experienced a statistically significantly higher mean (27.43) than both the 
American Indian or Alaska Native (17.40) and the Asian or Pacific Islander (11.10) groups while 
having a statistically significantly lower mean than the White group (49.81), all at the p<.05 
level. The White demographic also showed a statistically significantly higher mean mortality rate 




RQ7: How does age affect comortality for type 2 diabetes and acute myocardial infarction? 
The oldest two age groups (75-84 and 85+) were statistically significantly different when 
comparing the mean comortality rates to each other younger age group (Table 5). The mean 
comortality rate for the 75-84 age group (16.60) and 85+ age group (28.57), was statistically 
significantly higher (p<.05) than all the younger age groups and also statistically significantly 
lower (p<.05) than all the older age groups. The mean comortality rate for the 65-74 age group 
(7.99) was statistically significantly different to each group except the 25-34 age group (0.02), 
being significantly higher (p<.05) than all the younger age groups and significantly lower than 
the older age groups (p<.05). None of the means collected from the age groups between 25-64 




RQ8: How does gender affect comortality for type 2 diabetes and acute myocardial infarction? 
The mean comortality rates for these two diseases between males (M=2.7, SD=1.1) and females 
(M=2.1, SD=0.9) were not statistically significantly different. 
 
RQ9: How does race affect comortality from type 2 diabetes and acute myocardial infarction? 
The only statistically significant difference in mean mortality rate from the comortality of type 2 
diabetes and acute myocardial infarction was for persons identifying as Asian or Pacific Islander 
(Table 6). Mean comortality rate for Asian or Pacific Islander (.89) was significantly lower 
(p<.05) compared to American Indian or Alaska Native (2.52), Black or African American 





The connection between mortality stemming from type 2 diabetes and ageing was hypothesized 
to be a direct relationship, showing increasing in age matched with an increasing mortality from 
type 2 diabetes. The results from this study confirmed this hypothesis with an increase in 
mortality rates for patients who were 65 years old and older (Table 1). Advancing in age can 
increase the susceptibility of a patient to many disease processes and type 2 diabetes is one of the 
diseases which shows increased mortality with increasing age. In the Diabetes and Aging study 
conducted by Dr. Huang et al., the longer a patient was diagnosed with type 2 diabetes, the 
higher the mortality rate. In the same study, it was found that the age of the patient was also 
directly correlated with the mortality rate from type 2 diabetes.13  Confirming this study 
impresses the importance of keeping the age of patients living with type 2 diabetes in mind while 
formulating effective care and management for the individual.  
Another variable that can change the progression and mortality of diseases is gender and there is 
mixed data revolving around its effects on mortality from type 2 diabetes. In this study, the 
independent t-test did not show a connection between a certain gender and higher mortality rates 
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form type two diabetes. Even without statistical significance analysis, the mean death rates were 
surprisingly similar (RQ2). Some literature surrounding gender and its effects on type 2 diabetes 
has shown a connection between the female gender and increased total mortality from the 
disease.14 These mixed findings on a possible connection between type 2 diabetes mortality rate 
and gender demonstrates the need for additional research and clinical intrigue so healthcare 
professionals can better serve their patients.  
Race and its connections with diseases is a clinically significant research topic and its connection 
to type 2 diabetes continues to support that claim. This research shows a connection between a 
lower mortality rate from type 2 diabetes and patients identifying as being of Asian descent 
(Table 2). Current research also supports this claim, with a United States study conducted by Dr. 
Lee et al. stating that Asians with diabetes have a lower mortality rate than Whites with 
diabetes.15 Clinicians may be able to use this information to bolster risk evaluation techniques 
with patients who identify as member of a racial group.  
Moving towards the literature surround myocardial infarction, there is data supporting its 
connection with the ageing process. In a study conducted by Dr. Zhang et al., as patients 
continued to age, their prognosis worsen and mortality rates increased.16 The results from the 
ANOVA analysis in this research supports the notion that as patients age beyond the 65 year old 
threshold, the mortality rates from myocardial infarction also continue to increase (Table 3).  
Clinical application of these trends should show increased concern and attention to those patients 
whose age puts them at a potentially higher risk of mortality from myocardial infarction. 
As with type 2 diabetes, there exists literary disagreements over a possible connection between 
increased mortality rates from myocardial infarction and gender. Research conducted by Dr. 
Canto et al. analyzing both age and gender found that younger women were at a higher risk for 
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mortality due to myocardial infarction, but as patient’s age increased, the male rate of mortality 
increased.17 In contrast, the results of this project indicated no statistical evidence to show that 
males or females were at risk for a higher mortality rate. It should be noted that out of the three 
gender analyses conducted for this paper, the mean mortality rates for myocardial infarction 
alone between the two genders were the most different (RQ5). Although gender might not have 
statistically significant findings in this study, more research should be conducted to provide more 
evidence for this research question. 
Racial differences in the mortality from myocardial infarction has been a topic of research in 
many studies and the results depend largely on sample size, geography, and sampling method. In 
this research, it was shown that being African American or White increases the mortality rate of 
myocardial infarction as compared to Asian or American Indian (Table 4). It should also be 
noted that a difference was found between African American and White mortality rates, showing 
that the mortality rate for the White population was significantly higher than the African 
American population (Table 4). Research conducted by Dr. Zhang et al. lends some support and 
further insight into this argument from their study in 2016, showing that patients of White racial 
identification had a higher clinical manifestation rate of myocardial infarction. Although, another 
finding from the study showed those of Black identification having a non-statistically significant 
higher rate of non-clinically documented myocardial infarction.18 Elucidating the difference 
between incidence rates of subclinical and clinical myocardial infarction is out of the scope for 
this study, but the differences between the rates should be taken into consideration. These studies 
lend support for clinicians to add or stress racial risk as a part of the identification, prevention, 
and treatment of myocardial infarction.  
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The comortality from type 2 diabetes and myocardial infarction has been researched before and 
the results have correlated with the effects of age on each of the diseases individually. In a study 
conducted by Dr. Zoungas et al., diabetes and age were associated with higher rates of 
macrovascular events (such as myocardial infarction) and death from those events.19 The 
research in this paper supports these findings, showing an increase in mortality rate as a patient 
age rises above the 65 year mark (Table 5). There was a slight discrepancy in the statistically 
significant findings between the 65-74 and 25-34 age groups but this I believe to be a computing 
error by the ANOVA system, considering the mean mortality rates were 7.99 and 0.02 
respectively.  For patients aged 65+, there is evidence that suggests clinicians should address the 
risk of comortality between these diseases and modulate the care of their patients accordingly.  
Gender and its effect on the comortality from type 2 diabetes and myocardial infarction presents 
with similar uncertainty in the literature as with each of the disease individually. Dr. Lee et al. 
conducted research which showed a possibly lower mortality rate in men from type 2 diabetes 
and coronary heart disease (such as myocardial infarction) and a non-statistically significant 
increased mortality risk for women.20 The research conducted in this paper also showed 
inconclusive evidence that one of the genders experienced a higher mortality rate from both of 
the diseases (RQ8). Although there is conflicting evidence over the impact of gender on the 
comortality of these two diseases, the topic still should remain a point of discussion and further 
research with clinical researchers and medical professionals.  
The connection between race and the comortality from type 2 diabetes and acute myocardial 
infarction has been studied in the scientific community and the results of some of their research 
papers match the results from this study. In a study conducted by Dr. Ma et al., there was 
evidence to show that persons of Asian dissent had a lower risk of coronary heart disease than 
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their European counterparts.21 Another study conducted by Dr. Raffield et al. found that persons 
identifying as European American had an increased risk of cardiovascular disease mortality.22 
the research from this study shows similar results, with those of Asian American identification 
showing a decreased mortality rate from the comortality of these diseases (Table 6). Race should 
be another possible risk factor to be discussed and accounted for when working with patients 
who have comorbidity between type 2 diabetes and myocardial infarction.  
 
Conclusion 
Analyzing the mortality between type 2 diabetes and acute myocardial infarction can provide 
insightful discovers about risk but it can also present problems and limitations depending on 
what source data is used. A strength of this research is through using the CDC Wonder datasets, 
Multiple Causes of Death and Detailed Mortality, a large population was able to be analyzed 
over 18 consecutive years. A limitation with is data could be the accuracy and pervasive use of 
death certificates. Multiple causes of death might not have been identified on the death 
certificates and there may be undocumented deaths not accounted for, leading to skewed data. 
The data from this study still provides perspective into this continually evolving field of research 
and futures directions in this research could include: looking into the mechanism of action that 
connect type 2 diabetes and acute myocardial infarction, statistically supporting other risk 
factors, identifying health disparities in treatment, and looking at the comorbidity of the two 
diseases. This research paper shows how certain age, gender, and racial identifications can affect 
the mortality rates from type 2 diabetes, acute myocardial infarction, and the comortality 
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